PROS1 and cancer: A plasmonic-based ELISA (Enzyme-Linked ImmunoSorbent Assay) was reported for the detection of the prostate specific antigen (PSA) (model cancer biomarker) using two enzyme-free and isothermal nucleic acid amplification methods: hybridization chain reaction (HCR) and catalyzed hairpin assembly (CHA) [57].